Condition
Gene Mutation
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02000089Phase 3Recruiting
The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT05903690Early Phase 1CompletedPrimary
Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation
NCT03764371UnknownPrimary
Effects of Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma Patients
NCT03358459Unknown
Omics-based Precision Medicine of Epilepsy
Showing all 4 trials